Login / Signup

Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?

Kahina SakerBruno PozzettoAntonin BalMartine ValetteJean Baptiste FassierCarla SaadeMary Anne TrabaudSophie Trouillet-Assantnull null
Published in: Clinical chemistry (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • binding protein
  • dengue virus
  • dna binding
  • zika virus
  • aedes aegypti